317sek
3,6 %
Date:2026-01-20Time:18:00:00Latest report:Q3-2025List:Small CapTicker:ACE
Market Cap:405 msekEnterprise Value:334 msekNet Sales:- msekEarnings:-88,7 msekEmployees:0ISIN:SE0010573113

Ratios

10-year key figure history for Ascelia Pharma turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Ascelia Pharma with index and moving average MA50 and MA200.

Stockprice:3,17
MA50:2,99
MA200:3,70
Price/MA200:-14,3 %
RSI (14):54,1
Price/MA50:5,9 %

Description

Ascelia Pharma is a pharmaceutical company. The company specializes in the development of orphan drugs in oncology (cancer). The company develops various drug candidates, where the greatest use is found in the treatment of cancer affecting the liver and stomach. The company was founded in 2000 and is headquartered in Malmö, Sweden, but operates in a global market.

Pharmaceuticals